Update on novel targets and potential treatment avenues in pulmonary hypertension.
about
Opsin 3 and 4 Mediate Light-Induced Pulmonary Vasorelaxation that is Potentiated by G-Protein Receptor Kinase 2 Inhibition.Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1 targeted and dependent mechanism in PASMCs.Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.Accepting the challenge: maintaining AJP-Lung as the best place to publish basic and translational studies in lung biology and pathophysiology.
P2860
Update on novel targets and potential treatment avenues in pulmonary hypertension.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Update on novel targets and potential treatment avenues in pulmonary hypertension.
@en
Update on novel targets and potential treatment avenues in pulmonary hypertension.
@nl
type
label
Update on novel targets and potential treatment avenues in pulmonary hypertension.
@en
Update on novel targets and potential treatment avenues in pulmonary hypertension.
@nl
prefLabel
Update on novel targets and potential treatment avenues in pulmonary hypertension.
@en
Update on novel targets and potential treatment avenues in pulmonary hypertension.
@nl
P2093
P2860
P1476
Update on novel targets and potential treatment avenues in pulmonary hypertension.
@en
P2093
John C Huetsch
Karthik Suresh
Larissa A Shimoda
Meghan Bernier
P2860
P304
P356
10.1152/AJPLUNG.00302.2016
P577
2016-09-02T00:00:00Z